...
机译:Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world
First Department of Medicine,Charles University and General University Hospital;
Department of Hematology and Oncology, Faculty of Medicine,Masaryk University and University;
Department of Haemato‐Oncology, Faculty of Medicine and Dentistry,Palacky University and University4th Department of Internal Medicine ‐ Hematology, Faculty of Medicine,Charles University andDepartment of Internal Medicine – Hematology, Third Faculty of Medicine,Charles University andDepartment of Haemato‐Oncology, Faculty of Medicine,Charles University and University HospitalDepartment of Hematology,Medical Faculty of the Ostrava University and University Hospital;